Allergic conjunctivitis (AC) is an inflammation of the conjunctiva secondary to an immune response to external antigens, usually called allergens. This inflammation could be IgEmediated and non-IgE mediated and atopy could play a significant role in clinical evolution. (Johansson et al., 2004) AC is not a single disease; in fact it is a syndrome affecting the entire ocular surface, including conjunctiva, lids, cornea, and tear film. The signs and symptoms of allergic conjunctivitis have a meaningful effect on comfort and patient health, and are influenced by genetics, environment, ocular microbiota, and immune regulation mechanisms, all of which work together in a complex immunological response. Dysregulation in such immune homeostasis could turn into a variety of allergic ocular diseases (AOD). This chapter describes the current understanding of cellular and molecular pathways involved in different AOD, the clinical characteristics of ocular allergies, the new therapies related to control of immune activation, and the importance of basic research to generate new types of immunotherapy to treat allergic conjunctivitis
CITATION STYLE
Robles-Contreras, A., Santacruz, C., Ayala, J., Bracamontes, E., Godinez, V., Estrada-Garcia, I., … C., M. (2011). Allergic Conjunctivitis: An Immunological Point of View. In Conjunctivitis - A Complex and Multifaceted Disorder. InTech. https://doi.org/10.5772/26470
Mendeley helps you to discover research relevant for your work.